Global Hydroxyprogesterone Caproate Injection Market Insights, Forecast to 2025

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.
AMAG Pharmaceuticals is the leading manufacturer worldwide with the revenue market share of 83%, followed by Mcguff Pharmaceuticals Inc, Aspen Oss B.V, American Regent, Inc., and Mylan Institutional. North America and Europe are the two biggest selling regions, with the combined sales market share of 72%. In the forecast period, Asia-Pacific is expected to see the rapidest development.
The global Hydroxyprogesterone Caproate Injection market is valued at 251.1 million US$ in 2018 and will reach 295.5 million US$ by the end of 2025, growing at a CAGR of 1.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hydroxyprogesterone Caproate Injection market based on company, product type, end user and key regions.

This report studies the global market size of Hydroxyprogesterone Caproate Injection in key regions like North America., focuses on the consumption of Hydroxyprogesterone Caproate Injection in these regions.
This research report categorizes the global Hydroxyprogesterone Caproate Injection market by top players/brands, region, type and end user. This report also studies the global Hydroxyprogesterone Caproate Injection market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AMAG Pharmaceuticals
Mcguff Pharmaceuticals Inc
Aspen Oss B.V
American Regent, Inc.
Mylan Institutional

Hydroxyprogesterone Caproate Injection market size by Type
1 mL Injection
5 mL Injection

The 5 mL Injection accounted for a larger market share of 52% in 2018, but it was projected to be exceeded by the 1mL one in 2025.

Hydroxyprogesterone Caproate Injection market size by Applications
Hospitals Injection
Clinics Injection

Hospital took a larger market share of 51% in 2018, but it was expected to be exceeded by the Clinic in 2025.

Market size by Region
North America
United States
South Korea
Central & South America
Middle East & Africa
GCC Countries
South Africa

The study objectives of this report are:

To study and analyze the global Hydroxyprogesterone Caproate Injection market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hydroxyprogesterone Caproate Injection market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hydroxyprogesterone Caproate Injection companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hydroxyprogesterone Caproate Injection submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Hydroxyprogesterone Caproate Injection are as follows:
History Year: 2014-2018

Base Year:


Estimated Year:

Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hydroxyprogesterone Caproate Injection market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports